** Shares of Sun Pharma Advanced Research Co SPRC.NS fall
as much as 2% to 169.7 rupees
** Clinical-stage bio pharma co says IT security incident
occurred earlier this month and steps are taken to contain and
mitigate its impact
** Says there could be potential breach of certain file
systems and theft of data
** Adds it may incur expenses in connection with the
incident and remediation, but currently unable to determine
costs and other potential adverse impacts
** Parent Sun Pharmaceutical Industries SUN.NS up 1.4%
despite saying it expects revenues in some of its businesses to
be reduced due to the IT incident
** SPRC and SUN down ~17% and ~3% respectively this year, vs
5.5% decline in the Nifty Pharma Index .NIPHARM
(Reporting by Aleef Jahan in Bengaluru)
((aleefjahan.cs@thomsonreuters.com))